Martin Shkreli Was Apparently Live Streaming When FBI Agents Called
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St futures rise on Mideast deal optimism; SpaceX debut in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Oil falls to near two-month lows as Trump calls off threatened strikes on Iran
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Wall St set to gain on tech rebound, Middle East in focus
Glancy Prongay & Murray LLP Commences Investigation on Behalf of KaloBios Pharmaceuticals, Inc. Investors
December 17, 2015 1:53 PM ESTLOS ANGELES--(BUSINESS WIRE)-- Glancy Prongay & Murray LLP (GPM) is investigating potential claims on behalf of investors of KaloBios Pharmaceuticals, Inc. (KaloBios or the Company) (NASDAQ:... More
Nasdaq Halts KaloBios Pharmaceuticals, Inc.
December 17, 2015 10:41 AM ESTNEW YORK, Dec. 17, 2015 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that trading was halted today in KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) at 06:48:07 Eastern Time for "additional information requested" from the company at a last price of $23.59.
... More